Skip to search formSkip to main contentSkip to account menu

Osanetant

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

SR 142801

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
1999
1999
Crystallization Process of osanetant.
Crystallization process of osanetant, characterized in that i) osanetant is crystallized containing less than 20% impurities in… 
1999
1999
Crystal forms of osanetant
1999
1999
(R) - (+) - n - [[3- [1- benzoyl-3- (3,4-dichlorophenyl) piperidin-3-yl] prop-1-yl] -4-phenyl-piperidin-4-yl] crystalline forms and their preparation of -n- methylacetamide (osanetant)
1998
1998
Dihalophenyl-2,6-dioxo piperidine-3-propionic alkyl esters useful as intermediates for osanetant, an NK3 receptor specific antagonist